Established in 2011, SnackSafely.com provides straightforward, actionable information to help improve the lives of the estimated 32 million people in the US suffering with food allergies.

We strive to eliminate anaphylaxis by leveraging our on-line properties to educate, advocate, and connect the allergic community with products and services that help toward achieving this goal.

Our blog covers topics of interest to the food allergy community including news reports; ongoing research, clinical studies, trials and progress toward treatment and cure; general advocacy; and advice regarding food safety and school policies.

Please see our Terms of Service and Privacy Policy.

Emerging Therapy

BlueWillow Awarded NIH Contract to Advance Development of its Therapeutic Peanut Allergy Vaccine

ARS Completes Repeat Dosing Study of Nasal Epinephrine Required by FDA with Favorable Results

Breakthrough Food Allergy Therapies and the Big Business Behind Them

New Cancer Treatment May Prove Effective Against Food Allergies

Dr Edwin Kim Receives $1-Million Grant for Novel Multi-Nut Allergy SLIT Treatment Study

Nanoparticle Based Vaccines to Treat, Prevent Severe Allergic Reactions

FDA Approves Dupixent® (dupilumab) for Moderate-to-severe Atopic Dermatitis in Adolescents

Promising Food Allergy Treatment from Aravax Receives $12 Million Investment

Revolo Biotherapeutics Announces Open Enrollment for Phase 2 Clinical Trial of...

Intrommune Therapeutics Seeks Crowdfunding for Novel Toothpaste Immunotherapy

Study: Peanut OIT Increases Allergic Reactions, Compared with Avoidance or Placebo

FAQ for Palforzia, the First FDA Approved Therapy for Food Allergy

Study: Drug Increases Speed and Safety of OIT for Multiple Allergies

IgGenix Secures $40M Funding to Advance Antibody Therapy to Treat Food...

Peanut Allergy Vaccine to Rewrite the Immune System

Follow Us

Your School On Our Map

Put Your School on the Map